Hospitalization for XXXX in the United States.

@entity1 @entity1318 @entity295 @entity1174 @entity1576
AIM: To assess the outcome of different treatments in @entity1 admitted for @entity1318 in the United States. METHODS: This is a retrospective analysis using the Nationwide Inpatient Sample over an 8-year period (2003-2010). @entity1 admitted with a primary diagnosis of @entity1318 were divided into 3 groups based on their treatment: (1) Group 1: @entity1 who underwent Heller myotomy during their hospital stay; (2) Group 2: @entity1 who underwent esophagectomy; and (3) Group 3: @entity1 not undergoing surgical treatment. Primary outcome was in-hospital mortality. Secondary outcomes included length of stay (LOS), discharge destination and total hospital charges. RESULTS: Among 27141 @entity1 admitted with @entity1318 , nearly half (48.5%) underwent Heller myotomy, 2.5% underwent esophagectomy and 49.0% had endoscopic or other treatment. @entity1 in group 1 were younger, healthier, and had the lowest mortality when compared with the other two groups. Group 2 had the highest LOS and hospital charges among all groups. Group 3 had the highest mortality (1.2%, P < 0.001) and the lowest home discharge rate (78.8%) when compared to the other groups. The most frequently performed procedures among group 3 were esophageal dilatation (25.9%) and injection (13.3%). Among @entity1 who died in this group the most common associated morbidities included acute @entity1576 , @entity295 and @entity1174 . CONCLUSION: Surgery for @entity1318 carries exceedingly low mortality in the modern era; however, in complicated @entity1 , even less invasive treatments are burdened by significant mortality and morbidity.
